tbrc

  The custom antibody market size has grown rapidly in recent years. It will grow from $0.47 billion in 2025 to $0.53 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to growth in biomedical research, expansion of diagnostics testing, increased pharma r&d spending, advances in antibody engineering, growth of academic research. The custom antibody market size is expected to see rapid growth in the next few years. It will grow to $0.86 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to growth in personalized medicine, expansion of biologics research, increasing cro utilization, rising diagnostic demand, growth in precision oncology. Major trends in the forecast period include rising demand for tailored research antibodies, increasing use in precision diagnostics, growing adoption in drug discovery pipelines, expansion of recombinant antibody...

  The ctla4 inhibitors market size has grown rapidly in recent years. It will grow from $5.63 billion in 2025 to $6.54 billion in 2026 at a compound annual growth rate (CAGR) of 16.2%. The growth in the historic period can be attributed to advances in cancer immunology research, approval of first CTLA4 inhibitors, rising cancer incidence rates, strong investment in oncology R&D, increased regulatory support for biologics. The ctla4 inhibitors market size is expected to see rapid growth in the next few years. It will grow to $11.84 billion in 2030 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to growth in precision oncology adoption, expansion of combination immunotherapy regimens, rising demand for durable cancer responses, increasing oncology pipeline activity, global expansion of cancer treatment infrastructure. Major trends in the forecast period include increasing use of immunotherapy in oncology, growing adoption of...

  The cryptococcosis therapeutics market size has grown strongly in recent years. It will grow from $4.13 billion in 2025 to $4.36 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to limited availability of antifungal therapeutics, high prevalence of immunocompromised patients, reliance on hospital-based treatment, predominance of branded drugs, slow adoption of oral formulations. The cryptococcosis therapeutics market size is expected to see strong growth in the next few years. It will grow to $5.33 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increasing incidence of cryptococcosis in developing regions, development of novel antifungal agents, rising awareness among healthcare providers, expansion of online pharmacy channels, growing investment in combination and targeted therapies. Major trends in the forecast period include rising adopt...

  The cryogenic vaporizer market size has grown strongly in recent years. It will grow from $5.19 billion in 2025 to $5.48 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to growth in industrial gas consumption, expansion of oil and gas processing facilities, established use of cryogenic storage systems, demand from metallurgical industries, increased use of oxygen and nitrogen gases. The cryogenic vaporizer market size is expected to see strong growth in the next few years. It will grow to $6.89 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to growth in LNG transportation infrastructure, rising demand for medical oxygen systems, expansion of hydrogen and clean energy projects, increasing industrial automation, demand for efficient gas handling equipment. Major trends in the forecast period include rising use of cryogenic gases in industrial ...

  The crohn's disease treatment market size has grown strongly in recent years. It will grow from $13.1 billion in 2025 to $13.99 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing crohn’s disease prevalence, growing awareness of inflammatory bowel diseases, expansion of hospital pharmacy networks, availability of conventional anti-inflammatory drugs, improved diagnostic capabilities. The crohn's disease treatment market size is expected to see strong growth in the next few years. It will grow to $18.86 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to pipeline expansion of biologics and small molecules, rising demand for personalized treatment, growth of online pharmacy penetration, increasing healthcare expenditure in emerging markets, long-term disease management focus. Major trends in the forecast period include rising adopt...

  The critical care drugs market size has grown strongly in recent years. It will grow from $1.13 billion in 2025 to $1.2 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising incidence of critical illnesses, increasing icu admissions, limited availability of advanced critical care drugs, growing hospital infrastructure, reliance on conventional sedatives and analgesics. The critical care drugs market size is expected to see strong growth in the next few years. It will grow to $1.53 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to development of novel opioids and sedatives, integration of ai-based monitoring and dosing tools, expansion of acute care protocols, rising government initiatives for icu capacity building, increasing adoption of precision critical care therapies. Major trends in the forecast period include increasing use of adva...

  The critical care antiarrhythmic drugs market size has grown strongly in recent years. It will grow from $1.06 billion in 2025 to $1.13 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to high incidence of acute cardiac arrhythmias, established role of antiarrhythmic drugs in intensive care units, expansion of emergency cardiac care services, availability of proven intravenous drug formulations, growth in hospital-based critical care infrastructure. The critical care antiarrhythmic drugs market size is expected to see strong growth in the next few years. It will grow to $1.39 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to rising prevalence of cardiovascular diseases, increasing aging population with cardiac risk factors, expansion of intensive care and emergency services, growing focus on early arrhythmia intervention, demand for rapid sta...

  The covid-19 drug associated apis market size has grown strongly in recent years. It will grow from $7.14 billion in 2025 to $7.55 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to initial surge in covid-19 cases, urgent need for repurposed drugs, limited availability of antiviral apis, dependency on imports from asia-pacific, accelerated emergency approvals. The covid-19 drug associated apis market size is expected to see strong growth in the next few years. It will grow to $9.69 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to development of next-generation antiviral and immunomodulator apis, expansion of domestic api manufacturing, increasing adoption of biotech synthesis, rising government funding for pandemic preparedness, growing demand for diversified covid-19 treatment options. Major trends in the forecast period include rising dem...

  The covid-19 current therapy market size has declined steeply in recent years. It will decline from " $2.35 billion in 2025 to $1.57 billion in 2026 at a compound annual growth rate (CAGR) of -33.2%. The decline in the historic period can be attributed to sudden outbreak of covid-19, high hospitalization rates, limited initial therapeutic options, decreasing government and healthcare initiatives, less emergency approvals for drugs. The covid-19 current therapy market size is expected to see steep decline in the next few years. It will decline to $0.31 billion in 2030 at a compound annual growth rate (CAGR) of -33.2%. The decline in the forecast period can be attributed to decreasing telemedicine adoption for covid-19 management, less expansion of home care services. Major trends in the forecast period include rising adoption of antiviral and monoclonal antibody therapies, increased use of corticosteroids for severe covid-19 cases, growth in home care and remote patient monitor...

  The cough syrups market size has grown strongly in recent years. It will grow from $6.8 billion in 2025 to $7.25 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to seasonal respiratory infections, otc medicine availability, pediatric cold prevalence, pharmacy retail expansion, urban pollution. The cough syrups market size is expected to see strong growth in the next few years. It will grow to $9.3 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to natural ingredient demand, self-medication trends, pediatric healthcare focus, online pharmacy growth, respiratory illness incidence. Major trends in the forecast period include rising demand for pediatric formulations, growth of herbal and natural cough syrups, expansion of combination medications, increased otc product consumption, focus on sugar-free and alcohol-free syrups. Claim Your Free Rep...

  The cough and cold preparations market size has grown steadily in recent years. It will grow from $88.07 billion in 2025 to $91.38 billion in 2026 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to increasing prevalence of seasonal flu and common cold, growth in over-the-counter drug sales, rising awareness about respiratory health, expansion of retail pharmacy networks, availability of combination cold and cough medications. The cough and cold preparations market size is expected to see steady growth in the next few years. It will grow to $109.88 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to development of targeted antiviral drugs, adoption of personalized medicine approaches, integration of herbal and natural therapies, increasing demand for fast-acting symptom relief, expansion of online pharmacy channels. Major trends in the forecast period include ...

  The cosmetic ingredients market size has grown strongly in recent years. It will grow from $33.31 billion in 2025 to $35.36 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to growth of personal care and beauty industry, increasing urbanization and disposable income, expansion of global cosmetic manufacturing, rising awareness of personal grooming, availability of diverse synthetic ingredients. The cosmetic ingredients market size is expected to see strong growth in the next few years. It will grow to $46.35 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to surge in demand for clean and sustainable beauty products, innovation in bio-based and specialty ingredients, increasing focus on anti-aging and functional cosmetics, expansion of premium skin and hair care segments, regulatory push for safer cosmetic formulations. Major trends in the fore...

  The cosmeceuticals market size has grown strongly in recent years. It will grow from $64.68 billion in 2025 to $70.07 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising awareness of skin health, increasing urbanization and pollution exposure, growth of middle-class spending on personal care, expansion of dermatology clinics, increasing prevalence of skin disorders. The cosmeceuticals market size is expected to see strong growth in the next few years. It will grow to $99.61 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to advances in active ingredient formulations, increasing preference for premium cosmeceuticals, growth of male grooming products, expansion in emerging markets, rising influence of social media and beauty influencers. Major trends in the forecast period include growing demand for anti-aging and preventive skincare, ris...